SEC Filings

Form 6-K
AURIS MEDICAL HOLDING AG filed this Form 6-K on 01/30/2018
Document Outline
Entire Document (678.6 KB)
Subdocument 1 - 6-K - FORM 6-K
Page 1 - UNITED STATES
Page 2 - INCORPORATION BY REFERENCE
Page 3 - N/A
Page 4 - SIGNATURE
Page 5 - EXHIBIT INDEX
Subdocument 2 - EX-1.1 - EXHIBIT 1.1
Page 1 - Exhibit 1.1
Page 2 - Investment Banking Agreement
Page 3 - Incorporated Documents
Page 4 - Offering Materials
Page 5 - Certificates
Page 6 - Registration Statement Matters
Page 7 - Prospectus Delivery Period
Page 8 - Periodic Reporting Obligations
Page 9 - Section 5. Conditions of the Obligations of the Placement Agent
Page 10 - No Material Adverse Change
Page 11 - Stock Exchange Listing
Page 12 - Blue Sky Survey
Page 13 - With a copy to:
Page 14 - Section 13. General Provisions
Page 15 - N/A
Page 16 - Annex A
Subdocument 3 - EX-4.1 - EXHIBIT 4.1
Page 1 - Exhibit 4.1
Page 2 - Affiliate
Page 3 - The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
Page 4 - Registration Unavailability Period
Page 5 - Standard Settlement Period
Page 6 - No Fractional Shares or Scrip
Page 7 - Holder s Exercise Limitations
Page 8 - Beneficial Ownership Limitation
Page 9 - Fundamental Transaction
Page 10 - Black Scholes Value
Page 11 - Calculations
Page 12 - Applicability of article 653d para. 2 Swiss Code Obligations.
Page 13 - Warrant Register
Page 14 - Conditional Capital
Page 15 - Governing Law
Page 16 - Successors and Assigns
Page 17 - N/A
Page 18 - EXHIBIT A
Page 19 - EXHIBIT B
Subdocument 4 - EX-5.1 - EXHIBIT 5.1
Page 1 - Exhibit 5.1
Page 2 - Documents
Page 3 - N/A
Page 4 - Documents
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Subdocument 5 - EX-10.1 - EXHIBIT 10.1
Page 1 - Exhibit 10.1
Page 2 - Closing
Page 3 - FCPA
Page 4 - Placement Agent
Page 5 - Short Sales
Page 6 - Warrants
Page 7 - Deliveries
Page 8 - N/A
Page 9 - Failure to Close
Page 10 - Free Writing Prospectuses; Road Show.
Page 11 - No Material Adverse Change.
Page 12 - IFRS
Page 13 - Subsidiaries.
Page 14 - Non-Contravention of Existing Instruments; No Further Authorizations or Approvals Required
Page 15 - Required Approvals
Page 16 - USPTO
Page 17 - Insurance.
Page 18 - Environmental Laws
Page 19 - Foreign Corrupt Practices Act.
Page 20 - Money Laundering Laws
Page 21 - Foreign Private Issuer
Page 22 - Health Care Laws
Page 23 - Private Placement
Page 24 - Representations and Warranties of the Purchasers
Page 25 - Experience of Such Purchaser
Page 26 - General Solicitation
Page 27 - N/A
Page 28 - N/A
Page 29 - Furnishing of Information
Page 30 - Integration
Page 31 - Shareholder Rights Plan
Page 32 - Purchaser Party
Page 33 - Reservation of Common Shares
Page 34 - Variable Rate Transaction
Page 35 - Exercise Procedures
Page 36 - Passive Foreign Investment Company
Page 37 - Notices
Page 38 - No Third-Party Beneficiaries
Page 39 - Severability
Page 40 - Payment Set Aside
Page 41 - Saturdays, Sundays, Holidays, etc.
Page 42 - N/A
Page 43 - Signature of Authorized Signatory of Purchaser
Page 44 - N/A
Page 45 - Schedule I
Page 46 - Schedule II
Page 47 - Annex A
Page 48 - N/A
Page 49 - N/A
Page 50 - SELLING SHAREHOLDERS
Page 51 - N/A
Page 52 - Annex B
Page 53 - Nennwertr ckzahlungen
Page 54 - Teilbesteuerung
Page 55 - Material U.S. Federal Income Tax Considerations for U.S. Holders
Page 56 - de minimis
Page 57 - Taxation of Distributions
Page 58 - N/A
Page 59 - N/A
Page 60 - Annex C
Page 61 - and
Page 62 - Name